Diacetylaminoacetic acid ethylenediamine glucose injection

1. Pharmacological effects: (1) Inhibits plasminogen activator, preventing plasminogen from activating into plasmin, thereby inhibiting the dissolution of fibrin and producing a hemostatic effect. (2) Promotes the release of active substances from platelets. (3) Enhances capillary resistance and reduces capillary permeability, thereby reducing bleeding. 2. Toxicological studies: According to literature reports, the LD50 of intravenous injection of diacetylaminoacetic acid ethylenediamine in mice is 683.3 mg/kg.

Ethylenediamine diacetate

This product is a colorless clear liquid.

It is suitable for the prevention and treatment of bleeding due to various reasons, and has good curative effects on surgical bleeding, surgical bleeding, respiratory bleeding, bleeding from the five sense organs, gynecological bleeding, hemorrhoidal bleeding, urinary tract bleeding, cancer bleeding, digestive tract bleeding, and cerebral hemorrhage.

Intravenous drip. The usual dosage is 0.6g each time or follow the doctor's advice, and the maximum daily limit is 1.2g. In case of emergency, a large dose of intravenous injection and intravenous drip (please use diacetylaminoacetic acid ethylenediamine injection or diacetylaminoacetic acid ethylenediamine for injection) can be used at the same time for the first time.

The possible adverse reactions of this product include dizziness, slow heart rate, fatigue, skin numbness, fever, dry mouth, vomiting, nausea, etc. Most of them can disappear on their own or after stopping the drug.

It is contraindicated for those who are allergic to this product or medicines containing this product.

Not yet clear.

Keep in a light-proof and airtight container.

250ml: 0.6g diacetylaminoacetic acid ethylenediamine and 7.0g glucose